Abstract
IntroductionClinically evaluating genotypic interpretation systems is essential to provide optimal guidance in designing potent individualized HIV-regimens. This study aimed at investigating the ability of the latest Rega algorithm to predict virological response on a short and longer period.Materials & Methods9231 treatment changes episodes were extracted from an integrated patient database. The virological response after 8, 24 and 48 weeks was dichotomized to success and failure. Success was defined as a viral load below 50 copies/ml or alternatively, a 2 log decrease from the baseline viral load at 8 weeks. The predictive ability of Rega version 8 was analysed in comparison with that of previous evaluated version Rega 5 and two other algorithms (ANRS v2011.05 and Stanford HIVdb v6.0.11). A logistic model based on the genotypic susceptibility score was used to predict virological response, and additionally, confounding factors were added to the model. Performance of the models was compared using the area under the ROC curve (AUC) and a Wilcoxon signed-rank test.ResultsPer unit increase of the GSS reported by Rega 8, the odds on having a successful therapy response on week 8 increased significantly by 81% (OR = 1.81, CI = [1.76–1.86]), on week 24 by 73% (OR = 1.73, CI = [1.69–1.78]) and on week 48 by 85% (OR = 1.85, CI = [1.80–1.91]). No significant differences in AUC were found between the performance of Rega 8 and Rega 5, ANRS v2011.05 and Stanford HIVdb v6.0.11, however Rega 8 had the highest sensitivity: 76.9%, 76.5% and 77.2% on 8, 24 and 48 weeks respectively. Inclusion of additional factors increased the performance significantly.ConclusionRega 8 is a significant predictor for virological response with a better sensitivity than previously, and with rules for recently approved drugs. Additional variables should be taken into account to ensure an effective regimen.
Highlights
Evaluating genotypic interpretation systems is essential to provide optimal guidance in designing potent individualized HIV-regimens
Per unit increase of the Genotypic Susceptibility Score (GSS) reported by Rega 8, the odds on having a successful therapy response on week 8 increased significantly by 81% (OR = 1.81, confidence interval (CI) = [1.76–1.86]), on week 24 by 73% (OR = 1.73, CI = [1.69–1.78]) and on week 48 by 85% (OR = 1.85, CI = [1.80–1.91])
Rega 8 is a significant predictor for virological response with a better sensitivity than previously, and with rules for recently approved drugs
Summary
Evaluating genotypic interpretation systems is essential to provide optimal guidance in designing potent individualized HIV-regimens. Extended cross-resistance has been decreasing over calendar year and drug developers have been encouraged to focus their research on new potent drugs with a better tolerability, ease of use and less toxicity [4]. Several genotypic interpretation systems have proven to significantly predict virologic response in retrospective analyses [5,6,7] and are mentioned in treatment and resistance guidelines [8]. It remains a challenge to keep those interpretation systems up-to-date and improve their usefulness for clinicians treating HIV-infected patients [9]. New knowledge on resistance related mutations is accumulating and new drugs are still being implemented in clinical practice. Guidelines stress the fact that regular updating and proper clinical evaluation of interpretation algorithms is needed [8]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
